Back
Asure Software 10K Form
Sell
46
ASUR
Asure Software
Last Price:
9.73
Seasonality Move:
16.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ASUR/Asure Software Quarterly |
2023-11-13 | 10Q | ASUR/Asure Software Quarterly |
2023-08-07 | 10Q | ASUR/Asure Software Quarterly |
2023-05-08 | 10Q | ASUR/Asure Software Quarterly |
2022-11-07 | 10Q | ASUR/Asure Software Quarterly |
2022-08-08 | 10Q | ASUR/Asure Software Quarterly |
Receive ASUR News And Ratings
See the #1 stock for the next 7 days that we like better than ASUR
ASUR Financial Statistics
Sales & Book Value
Annual Sales: | $119.08M |
---|---|
Cash Flow: | $-9.78M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.50 |
Price / Book: | 1.17 |
Profitability
EPS (TTM): | -0.48000 |
---|---|
Net Income (TTM): | $-12.15M |
Gross Margin: | $85.54M |
Return on Equity: | -6.23% |
Return on Assets: | -2.82% |
Asure Software Earnings Forecast
Key Asure Software Financial Ratios
- The Gross Profit Margin over the past 34 years for ASUR is 71.83%.
- The Selling, General & Administrative Expenses for ASUR have been equal to 57.16% of Gross Profit Margin.
- The Research & Development expenses have been 5.75% of Revenue.
- The Interest Expense is -46.64% of Operating Income.
- The Net Earning history of ASUR is -7.74% of Total Revenues.
- Per Share Earnings over the last 34 years have been positive in 20 years.
Asure Software Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Professional Services |
Sector: | Industrials |
Current Symbol: | ASUR |
CUSIP: | 04649U |
Website: | asuresoftware.com |
Debt
Debt-to-Equity Ratio: | 0.04 |
---|---|
Current Ratio: | 1.07 |
Quick Ratio: | 0.13 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 9.69 |
ASUR Technical Analysis vs Fundamental Analysis
Sell
46
Asure Software (ASUR)
is a Sell
Is Asure Software a Buy or a Sell?
-
Asure Software stock is rated a Sell
The current Asure Software [ASUR] share price is $8.78. The Score for ASUR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.